← Back to Search

Behavioral Intervention

ECALC Program for Reducing College Student Alcohol Abuse (ECALC Trial)

N/A
Waitlist Available
Led By Michael E Dunn, Ph.D.
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1, 2, 3, 4, 13, and 26
Awards & highlights

ECALC Trial Summary

This trial is testing an online program to reduce alcohol use and risk in college students. It tracks their progress over 3 weeks, with boosters available to prevent decay.

Who is the study for?
This trial is for full-time first-year college students who drink alcohol, as indicated by specific AUDIT-C scores (5 or higher for women, 7 or higher for men), speak English fluently, and can consent to research. It excludes non-students, pregnant individuals, and those with very high AUDIT scores (15+).Check my eligibility
What is being tested?
The study tests a web-based program called ECALC designed to reduce alcohol use among college students. Participants complete the program and track their drinking habits over several months. Some will receive extra biweekly smartphone messages ('boosters') to see if they help maintain the program's benefits.See study design
What are the potential side effects?
Since this intervention involves educational content rather than medication, traditional physical side effects are not expected. However, participants may experience psychological discomfort when confronting their alcohol use behaviors.

ECALC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1, 2, 3, 4, 13, and 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 1, 2, 3, 4, 13, and 26 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Alcohol Expectancies Measured Daily with Ecological Momentary Assessment (EMA)
Change from Baseline in Alcohol Expectancies Measured Weekly with CEOA
Change from Baseline in Alcohol Use Measured Daily with Ecological Momentary Assessment (EMA)
+3 more

ECALC Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: ECALC Plus Weekly BoostersExperimental Treatment1 Intervention
Cognitive Behavioral Program to Change Expectancy Processes with Weekly Booster Content Delivered by Mobile Device
Group II: ECALCExperimental Treatment1 Intervention
Cognitive Behavioral Program to Change Expectancy Processes
Group III: ControlActive Control1 Intervention
Control Group Presentation on Body Image

Find a Location

Who is running the clinical trial?

University of Central FloridaLead Sponsor
78 Previous Clinical Trials
1,097,116 Total Patients Enrolled
Michael E Dunn, Ph.D.Principal InvestigatorUniversity of Central Florida

Media Library

ECALC (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05616247 — N/A
Alcohol Abuse Research Study Groups: Control, ECALC, ECALC Plus Weekly Boosters
Alcohol Abuse Clinical Trial 2023: ECALC Highlights & Side Effects. Trial Name: NCT05616247 — N/A
ECALC (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05616247 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment available for the current clinical trial?

"According to clinicaltrials.gov, the trial initiated on October 5th 2022 is not accepting participants at this time. The last update was made November 7th 2022, yet there are 256 other studies currently recruiting patients."

Answered by AI

Who else is applying?

What site did they apply to?
University of Central Florida
What portion of applicants met pre-screening criteria?
Met criteria
~139 spots leftby May 2025